Trials / Active Not Recruiting
Active Not RecruitingNCT05528302
Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment
Technology Assisted and Remotely Delivered Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment: Randomised Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- The University of Queensland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized controlled trial (RCT) of a remotely-delivered, technology-assisted psychotherapy program, supported by an innovative software platform for people with cognitive impairment experiencing anxiety.
Detailed description
Despite harmful health and economic consequences, anxiety is a vexing issue in persons with cognitive impairment with inadequate treatment options. What is needed currently is a digital technology option for treating anxiety in persons with cognitive impairment that can be rigorously evaluated and implemented. The objective of the study is to test the efficacy of a newly modified psychotherapy package (Tech-CBT), which incorporates Cognitive Behaviour Therapy (CBT) methods, assisted with technology and telehealth for persons with cognitive impairment experiencing anxiety. This project will also investigate the cost-effectiveness, usability and acceptability of Tech-CBT to enhance delivery of anxiety treatment for people with cognitive impairment. A process evaluation will inform its implementation in the community and memory clinics, and will recommend a strategic translational roadmap to enhance delivery of anxiety treatment in health services with a broad reach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tech-CBT intervention | The Tech-CBT intervention is a manualised package that incorporates Cognitive Behavioural Therapy methods. |
Timeline
- Start date
- 2023-02-20
- Primary completion
- 2025-10-22
- Completion
- 2026-04-15
- First posted
- 2022-09-06
- Last updated
- 2026-02-04
Locations
5 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT05528302. Inclusion in this directory is not an endorsement.